AEON Biopharma Management

Management criteria checks 2/4

AEON Biopharma's CEO is Marc Forth, appointed in Dec 2019, has a tenure of 5.17 years. total yearly compensation is $3.98M, comprised of 13.8% salary and 86.2% bonuses, including company stock and options. directly owns 0.088% of the company’s shares, worth $1.38K. The average tenure of the management team and the board of directors is 3.6 years and 1.7 years respectively.

Key information

Marc Forth

Chief executive officer

US$4.0m

Total compensation

CEO salary percentage13.8%
CEO tenure5.2yrs
CEO ownership0.09%
Management average tenure3.6yrs
Board average tenure1.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Marc Forth's remuneration changed compared to AEON Biopharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$14m

Jun 30 2024n/an/a

-US$306m

Mar 31 2024n/an/a

-US$137m

Dec 31 2023US$4mUS$550k

-US$385m

Sep 30 2023n/an/a

-US$393m

Jun 30 2023n/an/a

-US$78m

Mar 31 2023n/an/a

-US$66m

Dec 31 2022US$5mUS$550k

-US$53m

Sep 30 2022n/an/a

-US$25m

Jun 30 2022n/an/a

-US$27m

Mar 31 2022n/an/a

-US$61m

Dec 31 2021n/an/a

-US$56m

Sep 30 2021n/an/a

-US$58m

Jun 30 2021n/an/a

-US$54m

Mar 31 2021n/an/a

-US$17m

Dec 31 2020US$3mUS$524k

-US$50m

Compensation vs Market: Marc's total compensation ($USD3.98M) is above average for companies of similar size in the US market ($USD638.71K).

Compensation vs Earnings: Marc's compensation has been consistent with company performance over the past year.


CEO

Marc Forth (52 yo)

5.2yrs

Tenure

US$3,982,378

Compensation

Mr. Marc Forth serves as Chief Executive Officer at AEON Biopharma, Inc., since December 2019 and also serves as its Principal Financial Officer since May 17, 2024 and serves as its President. Prior to AEO...


Leadership Team

NamePositionTenureCompensationOwnership
Marc Forth
Principal Financial Officer5.2yrsUS$3.98m0.088%
$ 1.4k
Alex Wilson
Executive VP3.5yrsUS$1.40m0.025%
$ 401.6
Chad Oh
Chief Medical Officer3.7yrsUS$1.65m0.031%
$ 495.2
Jennifer Sy
Principal Accounting Officerless than a yearno data0%
$ 0

3.6yrs

Average Tenure

45yo

Average Age

Experienced Management: AEON's management team is considered experienced (3.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Marc Forth
Principal Financial Officer1.7yrsUS$3.98m0.088%
$ 1.4k
Robert Palmisano
Independent Director1.7yrsUS$197.87k2.83%
$ 44.7k
Shelley Thunen
Independent Director1.7yrsUS$198.86k0%
$ 0
Jost Fischer
Chairman8yrsUS$862.46k0.055%
$ 863.2
Eric Carter
Independent Director1.7yrsUS$216.91k0%
$ 0
Seongsoo Park
Directorless than a yearno datano data

1.7yrs

Average Tenure

70yo

Average Age

Experienced Board: AEON's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/27 12:56
End of Day Share Price 2025/02/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AEON Biopharma, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Douglas TsaoH.C. Wainwright & Co.